Targeting BRAF pathway in low-grade serous ovarian cancer-Reference-Cited by-同舟云学术

Targeting BRAF pathway in low-grade serous ovarian cancer

Published:2024 Issue:4 Volume:35 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Perrone Chiara¹^ORCID,Angioli Roberto²^ORCID,Luvero Daniela²^ORCID,Giannini Andrea¹^ORCID,Di Donato Violante¹^ORCID,Cuccu Ilaria¹^ORCID,Muzii Ludovico¹^ORCID,Raspagliesi Francesco³^ORCID,Bogani Giorgio³^ORCID

Affiliation:

1. Department of Gynecological, Obstetrical and Urological Sciences, Sapienza University of Rome, Rome, Italy.

2. Department of Gynecology, Campus Bio-Medico University Hospital Foundation, Rome, Italy.

3. Gynecologic Oncologic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

Publisher

XMLink

Link

https://ejgo.org/pdf/10.3802/jgo.2024.35.e104

Reference52 articles.

1. Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy

2. Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes

3. Clinical Development of BRAF plus MEK Inhibitor Combinations

4. The histological and molecular characteristics of early-onset colorectal cancer: a systematic review and meta-analysis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes;Expert Review of Anticancer Therapy;2024-09-03

2. HMOX1: A pivotal regulator of prognosis and immune dynamics in ovarian cancer;BMC Women's Health;2024-08-30

3. Past and present: a bibliometric study on the treatment of recurrent ovarian cancer;Frontiers in Pharmacology;2024-07-30